Hrt Financial LP Natera, Inc. Transaction History

Hrt Financial LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$59.21 - $92.9 $2.52 Million - $3.96 Million	42,584 Added 177.72%	66,545 $6.09 Million
Q4 2023 Feb 09, 2024	BUY	$37.55 - $62.64 $899,735 - $1.5 Million	23,961 New	23,961 $1.5 Million
Q1 2023 May 12, 2023	BUY	$36.57 - $58.29 $6.46 Million - $10.3 Million	176,637 New	176,637 $9.81 Million
Q3 2022 Nov 14, 2022	BUY	$36.93 - $56.68 $5.93 Million - $9.11 Million	160,644 New	160,644 $7.04 Million
Q2 2022 Aug 12, 2022	SELL	$28.13 - $44.54 $4.04 Million - $6.39 Million	-143,495 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$30.32 - $91.33 $4.35 Million - $13.1 Million	143,495 New	143,495 $5.84 Million
Q3 2021 Nov 15, 2021	SELL	$100.17 - $126.36 $10.9 Million - $13.7 Million	-108,442 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$86.05 - $119.72 $9.33 Million - $13 Million	108,442 New	108,442 $12.3 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.